SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001615774-18-006725
Filing Date
2018-07-20
Accepted
2018-07-20 16:30:44
Documents
1
Group Members
VIVO CAPITAL VIII, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A s111485_sc13da.htm SC 13D/A 111154
  Complete submission text file 0001615774-18-006725.txt   112845
Mailing Address NO. 15 ZHI TONG ROAD, ZHONGGUANCUN TECH PARK, CHANGPING DISTR. BEIJING F4 102200
Business Address NO. 15 ZHI TONG ROAD, ZHONGGUANCUN TECH PARK, CHANGPING DISTR. BEIJING F4 102200 86-10-82890088
SINOVAC BIOTECH LTD (Subject) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79318 | Film No.: 18962772
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 650-688-0818
Vivo Capital, LLC (Filed by) CIK: 0001674712 (see all company filings)

IRS No.: 203075737 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A